West Pharmaceutical Services, Inc.

NYSE:WST

250.73 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 2,892.72,951.12,885.52,830.72,146.71,843.61,7181,600.21,509.11,3981,421.71,368.21,266.41,192.61,104.71,055.71,051.11,020.1913.3699.7541.6490.7419.7396.9430.1469.1449.7452.5458.8412.9365.1348.7338.2329.6323.2308.7288.2253.3235.6190.1
Cost of Revenue 1,890.51,818.41,746.61,657.31,378.81,234.81,171.71,085.41,008.1943.9973.8938.7878.6853.6787.1752.1748.5728.3651.5505.9374.1334.9302.1280.8289.7289.1282.2288.5302265.1225.9222.1217.8221.4221.5206.7197.4174.4160.2128
Gross Profit 1,002.21,132.71,138.91,173.4767.9608.8546.3514.8501454.1447.9429.5387.8339317.6303.6302.6291.8261.8193.8167.5155.8117.6116.1140.4180167.5164156.8147.8139.2126.6120.4108.2101.710290.878.975.462.1
Gross Profit Ratio 0.3460.3840.3950.4150.3580.330.3180.3220.3320.3250.3150.3140.3060.2840.2870.2880.2880.2860.2870.2770.3090.3180.280.2930.3260.3840.3720.3620.3420.3580.3810.3630.3560.3280.3150.330.3150.3110.320.327
Reseach & Development Expenses 69.168.458.552.846.938.940.339.136.834.137.337.933.229.123.919.918.716.111.17.96.30000000000000000000
General & Administrative Expenses 0000000000000000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 338.5353.4316.9361.9302272.7262.9246239.8233228.7234.9218.1191.1187.7177.7159.3152.5144.8112.497.211182.673.467.777.970.570.272.869.96963.557.18557.845.641.532.229.926.6
Other Expenses 00000011.70-8.9-61.3000-2.9000-10.2-0.2-0.3-0.1-29.6-1.61.53735.732.331.930.729.623.12223.624.522.720.318.916.814.712
Operating Expenses 407.6421.8375.4414.7348.9311.6291.5285.1285.5328.4266272.8251.3223.1211.6197.6178178.8156.1120.6103.681.48174.9104.7113.6102.8102.1103.599.592.185.580.7109.580.565.960.44944.638.6
Operating Income 594.6710.9763.5758.7419297.2254.8229.7215.5125.7181.9156.7136.5115.9106106124.6113105.773.263.954.526.741.335.766.464.761.953.348.347.141.139.7-1.321.236.130.429.930.823.5
Operating Income Ratio 0.2060.2410.2650.2680.1950.1610.1480.1440.1430.090.1280.1150.1080.0970.0960.10.1190.1110.1160.1050.1180.1110.0640.1040.0830.1420.1440.1370.1160.1170.1290.1180.117-0.0040.0660.1170.1050.1180.1310.124
Total Other Income Expenses Net 5.64.8-62.910.3-0.33.5-6.51.9-17.5-3.8-7.6-4.2-23.1-16.9-27.1-19.9-14.3-24.1-19.3-9.4-22.7-7.5-9.5-13.4-11.1-9.3-36.8-4.2-26.1-5.7-6.4-4.3-5.7-2.5-10.5-2.2-2.9-6.7-0.61.9
Income Before Tax 600.2715.7700.6769418.7300.7248.3231.6198121.9174.3152.5113.49978.986.1110.388.986.463.841.24717.227.83.157.127.957.727.242.640.736.834-3.810.733.927.523.230.225.4
Income Before Tax Ratio 0.2070.2430.2430.2720.1950.1630.1450.1450.1310.0870.1230.1110.090.0830.0710.0820.1050.0870.0950.0910.0760.0960.0410.070.0070.1220.0620.1280.0590.1030.1110.1060.101-0.0120.0330.110.0950.0920.1280.134
Income Tax Expense 107.5122.3114.7107.272.55941.480.954.426.347.240.232.723.513.613.523.717.224.6-0.411.116.74.18.61.518.421.213.310.813.913.414.314.34.76.413.210.19.513.210.4
Net Income 492.7593.4585.9661.8346.2241.7206.9150.7143.695.6127.1112.380.775.565.372.68670.767.145.619.431.918.4-5.21.638.76.744.416.428.727.323.519.7-8.54.320.717.413.71715
Net Income Ratio 0.170.2010.2030.2340.1610.1310.120.0940.0950.0680.0890.0820.0640.0630.0590.0690.0820.0690.0730.0650.0360.0650.044-0.0130.0040.0820.0150.0980.0360.070.0750.0670.058-0.0260.0130.0670.060.0540.0720.079
EPS 6.757.997.888.94.683.272.82.041.961.331.791.611.191.120.981.111.331.081.050.750.570.750.33-0.0910.0250.650.10.670.250.430.430.370.32-0.140.0680.320.270.210.270.24
EPS Diluted 6.697.887.738.674.573.212.741.991.911.31.751.571.151.080.951.061.251.0210.710.560.750.33-0.0910.0250.640.10.670.250.430.430.370.31-0.140.0680.320.270.210.270.24
EBITDA 743.8844.1808.1879.7518.9403.2353.2326.2286.9217.7278.5252.2200183.4161.3166.4186.1157.5149.9122.994.584.882.874.775.9102.19793.88477.970.263.163.323.243.956.449.346.745.535.5
EBITDA Ratio 0.2570.2860.280.3110.2420.2190.2060.2040.190.1560.1960.1840.1580.1540.1460.1580.1770.1540.1640.1760.1740.1730.1970.1880.1760.2180.2160.2070.1830.1890.1920.1810.1870.070.1360.1830.1710.1840.1930.187